


Life Sciences Investors Beware: Private Equity Firm Settles Federal False Claims Act Suit Regarding Compounding Pharmacy It Managed

Supreme Court Revives False Claims Act Suit by Applying “Government Knowledge” Statute of Limitations
First Circuit Reaffirms FCA Retaliation Claims Are Not Subject to FRCP 9(b): Where There’s Smoke, There Could Be Fire

California Appellate Court Refuses to Enforce Employee Non-Solicitation Provision
Subscribe: Subscribe via RSS